.

Особливості клініки та перебігу гострих кишкових інфекцій у дітей першого року життя, інфікованих цитомегаловірусом: Автореф. дис… канд. мед. наук /

Язык: украинский
Формат: реферат
Тип документа: Word Doc
108 1907
Скачать документ

EOAAINUeEEE AeA?AEAAIEE IAAeE*IEE OI?AA?NEOAO

Ia i?aaao ?oeiieno

IAEA?AIEI Aaeaioeia A?eai?iaia

OAeE 616.36-053.1-07-08:617.7

AOAEOEAI?NOUe IOEEA?IAOO IAO??TH ? NIEAI?IO A EIIIEAENI?E OA?AI??OA
?AAA?E?OAOe?? O?II?*IEO CAOAI?THAAIUe AAIAOIA?E?A?II? NENOAIE

14.01.02 – aioo??oi? oai?iae

Aaoi?aoa?ao

aeena?oaoe?? ia caeiaoooy iaoeiaiai nooiaiy

eaiaeeaeaoa iaaee/ieo iaoe

Eoaainuee – 1999

Aeena?oaoe??th ? ?oeiien.

?iaioa aeeiiaia a Eoaainueeiio aea?aeaaiiio iaaee/iiio oi?aa?neoao?,
a?aeae?e? aeieia?/ii? aaiaoeee oa ?ioiieia?? Oe?a?inueeiai iaoeiaiai
a?a??i?/iiai oeaio?o oa 3-e i?nuee?e ee?i?/i?e e?ea?i? i. Eoaainueea IIC
Oe?a?ie.

Iaoeiaee ea??aiee: aeieoi? iaaee/ieo iaoe, i?ioani?

AeIA??I Ai?en THe?eiae/

Eoaainueeee aea?aeaaiee iaaee/iee oi?aa?neoao, i?ioani? eaoaae?e
aini?oaeueii? oa?ai?? ? 2

Io?oe?ei? iiiiaioe: aeieoi? iaaee/ieo iaoe, i?ioani?

OA?*AIEI Iaoae?y Ay/aneaa?aia

Ee?anueea iaaee/ia aeaaeai?y i?neyaeeieiiii? ina?oe ?i. I.E. Ooieea,
caa. eaoaae?ith aano?iaioa?ieia?? ? ae??oioa?ai??

aeieoi? iaaee/ieo iaoe, i?ioani?

NEIss*AIEI Ieaa Aieiaeeie?iae/

Aeiiaoeueeee aea?aeaaiee iaaee/iee oi?aa?neoao, caa. eaoaae?ith
i?iiaaeaaoeee aioo??oi?o oai?ia

I?ia?aeia onoaiiaa: Iaoe?iiaeueiee iaaee/iee oi?aa?neoao ?i.
I.I. Aiaiiieueoey IIC Oe?a?ie, eaoaae?a aini?oaeueii? oa?ai?? ? 2

Caoeno aeena?oaoe?? a?aeaoaeaoueny “21” 05 1999 ?. i 12:30 aiaeei? ia
can?aeaii? niaoe?ae?ciaaii? a/aii? ?aaee E 29.600.01 i?e Eoaainueeiio
aea?aeaaiiio iaaee/iiio oi?aa?neoao? IIC Oe?a?ie (348045, i. Eoaainuee,
ea. 50 ??//y Iai?iie Eoaainueea, 1; o. 54-85-57)

C aeena?oaoe??th iiaeia iciaeiieoenue a iaoeia?e a?ae?ioaoe?
Eoaainueeiai aea?aeaaiiai iaaee/iiai oi?aa?neoaoo (348045, i. Eoaainuee,
ea. 50 ??//y Iai?iie Eoaainueea, 1)

Aaoi?aoa?ao ?ic?neaiee “19” 04 1999 ?ieo

A/aiee nae?aoa? niaoe?ae?ciaaii? ?aaee

aeieoi? iaaee/ieo iaoe, i?ioani? __________
A.?. Eieii??oeue

3

CAAAEUeIA OA?AEOA?ENOEEA ?IAIOE

Aeooaeuei?noue i?iaeaie. O?ii?/ia iaoieia?y aaiaoia?e?a?ii? nenoaie
iaaeoi oa?aeoa?ia ye aeey ?iaeono??aeueieo ?aa?ii?a Oe?a?ie, cie?aia,
Aeiiaano, ui ?iaeoue aeooaeueiei iiaeaeueoa aea/aiiy ieoaiue iaoiaaiaco
oa ?aoe?iiaeueiiai e?eoaaiiy aeaieo caoai?thaaiue. Ii?yae c o?ii?/ieie
aaiaoeoaie (OA) a??onii? ao?ieia?? ? aeeiaieueiiai aaiaco ?nio? cia/ia
a?oia caoai?thaaiue ci?oaii?, aai iaaoi/iaii? ao?ieia??, a e?eoaaii?
yeeo iniiaia ?ieue iaeaaeeoue iaoiaaiaoe/i?e oa?ai?? (N.Ae. Iiaeeiiaa,
1993; A.Ae. Aiae, 1993, 1995; I.A. Oa?/aiei, 1996, 1997; I.ss. Aaaae,
1998).

Oe?iea ?iciianthaeaeaiiy ye aino?eo, oae o?ii?/ieo o?aaeaiue ia/?iee ?
aeia/iaea?aeieo oeyo?a na?aae in?a iieiaeiai iaea?eueo i?aoeacaeaoiiai
a?eo, ia??aeei c ?icaeoeii oneeaaeiaiue ? iani?e?iieo iane?aee?a,
cie?aia, oi?ioaaiiy niieo/aii? iaoieia?? aaiaoia?e?a?ii? nenoaie ?
i?aeoeoieiai? caeice, iaaeathoue aeai?e i?iaeai? aaeueie aeooaeueiee
caaaeueiiiaaee/iee oa?aeoa? (A.E. Oa?thiia, 1995; E.E. A?iiaoaanueea,
1997, 1999; I.ss. Aaaae, 1998, 1999).

Anoaiiaeaii, ui o in?a ?c niieo/aieie o?ii?/ieie o?aaeaiiyie ia/?iee ?
aeia/iaea?aeieo oeyo?a ??ciiai aaiaco iathoue i?noea nooo?a? ?iceaaee
a?io?i?/ieo iieaciee?a ? i?e?iaaiiaeeiai?ee (A.I. O?ieia ? ni?aaao.,
1993, 1994). Ca inoaii? ?iee c’yaeeenue ?iaioe noiniaii ?iceaae?a noaio
?ioiiiai aiiainoaco o aeaiiai eiioeiaaioo oai?eo. Iaeiae, iaaeinoaoiuei
aea/aieie caeeoathoueny ieoaiiy noaio aia?aaoe/iiai iaoaaie?cio oa
ae?aaeaiino? neiae?iio aiaeiaaiii? “iaoaaie?/ii?” ?ioieneeaoe?? – NI?
(E.E. A?iiaoaanueea, 1997, 1998) o in?a ?c o?ii?/iith iaoieia??th
aaiaoia?e?a?ii? nenoaie; ia ?ice?eoi ?o aca?iica’ycie ?c ?ioiieia?/ieie
iieacieeaie.

Caaaeueiii?eeiyoa oa?ai?y o?ii?/ieo o?aaeaiue aaiaoia?e?a?ii? nenoaie c
aeei?enoaiiyi niaciie?oee?a, aeia/ia?iieo cania?a, aaiaoii?ioaeoi??a,
iacaaaeaee noa? aoaeoeaiei. A iece? aeiaaee?a aeinyaiooa ?ai?n?y
oa?aeoa?eco?oueny iaaeinoaoiueith no?eeinoth ? o?eaae?noth, a oai??
iio?aaothoue i?iaaaeaiiy iiaoi?ieo eo?n?a e?eoaaiiy ye a
aiaoeaoi?iiiie?ee?i?/ieo oiiaao, oae ? a noaoe?iia?? (N.Ae. Iiaeeiiaa,
1993, 1999).

Iiia?aaei?ie aeine?aeaeaiiyie anoaiiaeaii, ui i?e ?ic?iaoe? iiaeo
cania?a e?eoaaiiy OA, a oiio /ene? ?ioiiei?aeoe??, o iaoe??io?a, ye?
no?aaeaeathoue ia o?ii?/io iaoieia?th aaiaoia?e?a?ii? nenoaie, ca
no/anieie i?aaenoaaeaiiyie iiaeiia a?aoiaoaaoenue /ooeea?noue
?ioiieiiiaoaioiuo ee?oei aei ?ioiiaeoeaieo i?aia?ao?a a oanoao in vitro,
ui ni?ey? i?aeaeuaiith aoaeoeaiino? i?iaiaeeii? oa?ai?? ?
?iaeea?aeoaeueiiio i?aeai?? i?aia?ao?a aeey iioei?caoe?? e?eoaaiiy
(A.I. Ae?aii?e ? ni?aaao., 1993; E.O. *a?iooaiei, 1993, 1995).

Aeoiaey/e c iniiaieo eaiie iaoiaaiaco OA iai oyaeeinue aeioe?eueiei
aea/eoe ia?niaeoeae i?aeaeuaiiy aoaeoeaiino? e?eoaaiiy oai?eo,
no?aaeaeath/eo ia o?ii?/io iaoieia?th aaiaoia?e?a?ii? nenoaie, c
aeei?enoaiiyi ioeea?iaoo iao??y (II) a eiiieaen? ?c nieai?iii. II –
i?aia?ao c iie?aaeaioiith oa?iaeieia?/iith ae??th, yeee noeioeth?
iaoaaie?/i? i?ioeane a ee?oeiao, aeoeao? neioac a?eeo ? ioeea?iiaeo
eeneio, ?aia?aoeaio ?aaaia?aoe?th, i?e?iaeio aioe?ioaeoe?eio
?acenoaioi?noue ? ia? i’yeee ?ioiiiiaeoethth/ee aoaeo (A.I. Cainueeia ?
ni?aaao., 1985, 1993). ?ai?oa aoea iieacaia aoaeoeai?noue II a
eiiieaeni?e oa?ai?? aino?eo ? o?ii?/ieo aaiaoeo?a A, ae?aceiai? oai?iae
? iece? ae?oa?o iaoieia?/ieo noai?a (A.A. Ia?aaea??e, 1983, 1988;
A.I. O?ieia, 1984, 1989, 1993).

Nieai?i – a?o/eciyiee i?e?iaei?e i?aia?ao, yeee io?eiothoue ?c naeac?iee
aaeeei? ?iaaoi? ooaeiae, ui aieiae?? aeaoieneeoth/ith, i?ioeaea?a?/iith
? aaiaoii?ioaeoi?iith ae??th ? ia ia? i?ioeiieacaiue aeey i?ecia/aiiy
(O.I. O??ion, 1998). Aea?? naia oeeo i?aia?ao?a iaa?oioiaoaaany
iie?aaeaioi?noth ?o oa?iaeieia?/ii? ae?? c iaoith cieaeaiiy aeoeaiino?
i?ioean?a ia?aeeniiai ieeneaiiy e?i?ae?a (IIE), noeioeyoe?? nenoaie
aioeieneaeaioiiai caoenoo, aeey e?ea?aeaoe?? NI? ? a?aeiiaeaiiy
?ioiieia?/iiai aiiainoaco oa aia?aaoe/iiai iaoaaie?cio.

Ca’ycie ?iaioe c iaoeiaeie i?ia?aiaie, ieaiaie, oaiaie. ?iaioa
aeeiioaaeanue a?aeiia?aeii aei iniiaiiai ieaio IAe? Eoaainueeiai
aea?aeaaiiai iaaee/iiai oi?aa?neoaoo ? ? o?aaiaioii IAe? “?ic?iaea
nenoaie ?ioiieia?/iiai iii?oi?eiao ? ?ioii?aaa?e?oaoe?? ?ia?oiee?a
iniiaieo aaeocae aaeeeiai i?iieneiaiai ae?iaieoeoaa ? a?oi ?eceeo
ianaeaiiy i?iieneiai? ciie Aeiiaano” (? aea?ae?a?no?aoe?? 019000242).

Iaoa ? caaea/? aeine?aeaeaiiy. Iaoith ?iaioe aoea ?ic?iaea aoaeoeaiiai
niiniao e?eoaaiiy ? ?aaa?e?oaoe?? oai?eo ia o?ii?/i? aaiaoeoe ??cii?
ao?ieia?? c aeei?enoaiiyi ioeea?iaoo iao??y ? nieai?io.

Aeey ?aae?caoe?? icia/aii? iaoe iinoaaeai? ianooii? eiie?aoi? caaea/?:

1. Aea/eoe aieea eiia?iaoe?? II ? nieai?io ia ee?i?ei-a?io?i?/i?
iieacieee o oai?eo ia OA.

2. I?iaiae?coaaoe aeeiai?eo ?ioiieia?/ieo iieaciee?a o oai?eo ia OA,
ye? io?eiaee II ? nieai?i.

3. Aeine?aeeoe aieea eiia?iaoe?? II ? nieai?io ia noai aia?aaoe/iiai
iaoaaie?cio, ia?aeeniiai ieeneaiiy e?i?ae?a ? nenoaie aioeieneaeaioiiai
caoenoo.

4. Aea/eoe a?aeaeaeai? ?acoeueoaoe e?eoaaiiy oai?eo ia OA c
aeei?enoaiiyi II ? nieai?io o ii??aiyii? c iniaaie, ye? io?eiaee
caaaeueiii?eeiyoo oa?ai?th.

5. ?ic?iaeoe eiie?aoi? iieacaiiy aei aeei?enoaiiy II ? nieai?io i?e
OA, iaa?oiooaaoe ?aoe?iiaeuei? noaie canoinoaaiiy aeaieo i?aia?ao?a.

Iaoeiaa iiaecia ?iaioe. Anoaiiaeaia iaoiaaiaoe/ia ?ieue neiae?iio
“iaoaaie?/ii? ?ioieneeaoe??” ? eiai ca’ycie ?c iieacieeaie aia?aaoe/iiai
iaoaaie?cio o oai?eo ia OA. Iaoiaaiaoe/ii iaa?oioiaaii canoinoaaiiy
eiia?iaoe?? II ? nieai?io a oa?ai?? oai?eo ia OA.

Aia?oa io?eiai? aeai? i?i aieea eiia?iaoe?? II ? nieai?io ia ee?i?/iee
ia?aa?a oa ?ioiieia?/i? ? a?io?i?/i? iieacieee o oai?eo ia OA.

I?aeoe/ia cia/ou?noue io?eiaieo ?acoeueoao?a. ?ic?iaeaii can?a e?eoaaiiy
oa iaaee/ii? ?aaa?e?oaoe?? oai?eo ia OA c aeei?enoaiiyi eiia?iaoe?? II
? nieai?io. Iieacaiiyi aei i?ecia/aiiy cai?iiiiiaaii? eiia?iaoe??
ne?ae aaaaeaoe /ano? caaino?aiiy iaoieia?/iiai i?ioeano, iaaeinoaoith
aoaeoeai?noue caaaeueiii?eeiyoeo aaiaoii?ioaeoi??a, noeeuei?noue aei
aea?a?/ieo ?aaeoe?e, iayai?noue aoi?eiieo ?ioiiaeao?oeeoieo noai?a ?
aiaeiaaiii? ?ioieneeaoe??. Aeey i?aeaeuaiiy aoaeoeai?no? e?eoaaiiy ?
i?iaaaeaiiy iaaee/ii? ?aaa?e?oaoe?? aeioe?eueii i?iaiaeeoe iiaoi?iee
eo?n e?eoaaiiy /a?ac 4-5 i?nyoe?a.

Aeey aecia/aiiy aoaeoeaiino? i?iaaaeaiiai e?eoaaiiy aeioe?eueii
aecia/aoe ianooii? iieacieee: ??aaiue “na?aaei?o iieaeoe”, cia/aiiy
aia?aaoe/iiai ca?yaeo (AC) oa ??aaiue O-ee?oei c oaeia?iith aeoeai?noth
(ND-4+). I?e ??ai? NI 0,8 a/e ? a?eueoa, cia/aii? AC 1,7 ? ieae/a,
ai?noo ND-4 28% oa iaioa c ?iia??i?noth 75±3% i?iaiico?oueny
iaaeinoaoi?e aoaeo a?ae i?iaaaeaiiy e?eoaaiiy, ui aeiaaa? i?iaaaeaiiy
iiaoi?iiai eo?no e?eoaaiiy.

Iniiai? ?acoeueoaoe i?iaaaeaieo aeine?aeaeaiue ai?iaaaeaeai? a ee?i?/io
i?aeoeeo oa?aiaaoe/ieo oa aano?iaioa?ieia?/ieo a?aeae?eaiue i?nueeeo
ee?i?/ieo e?ea?aiue ?? 3 ? 4 i. Eoaainueea, OII ii. E?aniiai Eo/a,
Aio?aoeeoo, E?aiaiii?, Ae/aanueea, E?aniiaeiia, Noaoaiiaa Eoaainueei?
iaeano?, Eoaainueeiai iaeaniiai aaiaoieia?/iiai oeaio?o.

Io?eiai? aeai? aeeth/ai? aei iaa/aeueiiai i?ioeano ia eaoaae?ao
aioo??oi?o Eoaainueeiai oa Aeiiaoeueeiai aea?aeaaieo iaaee/ieo
oi?aa?neoao?a, Oe?a?inueei? iaaee/ii? noiiaoieia?/ii? aeaaeai??
(Iieoaaa).

Iniaenoee aianie caeiaoaa/a. Aaoi?ii iniaenoi ee?i?/ii oa
?ino?oiaioaeueii ianoaaeaii 208 oai?eo ia OA. Niiooeoaa/ea i?eeiaea
o/anoue a i?iaaaeaii? eiiieaenieo aeine?aeaeaiue ?ioiiiai noaoono ?
a?io?i?/ieo iieaciee?a o ianoaaeaieo oai?eo. Naiino?eii aoei ?ic?iaeaii
can?a e?eoaaiiy oa iaaee/ii? ?aaa?e?oaoe?? c aeei?enoaiiyi eiia?iaoe??
II ? nieai?io ? i?iaaaeaia eiai ai?iaaaeaeaiiy a ee?i?/io i?aeoeeo. An?
oai??, a?aeiiino? i?i yeeo iaaaaeai? a aeena?oaoe??, iniaenoi
niinoa??aaeenue aaoi?ii i?ae /an aeeniaina?iiai iaaeyaeo i?ioyaii 2-3-o
?ie?a oa a?eueoa. Aaoi?ii i?iaaaeaia noaoenoe/ia ia?iaea ?acoeueoao?a
ee?i?/ieo, ?ioiieia?/ieo ? eaai?aoi?ieo iieaciee?a.

Ai?iaaoe?y ?iaioe. Iniiai? iieiaeaiiy aeena?oaoe?? aeieeaaeai? oa
iaaiai?ai? ia I?aeia?iaei?e iaoeiai-i?aeoe/i?e eiioa?aioe?? “Aeooaeuei?
ieoaiiy oai?aoe/ii? oa ee?i?/ii? iaaeeoeeie ia no/aniiio ??ai?”
(Iieoaaa, 1996), iaoeia?e eiioa?aioe?? c i?iaeai ee?i?/ii? ?ioiieia?? ?
aea?aieia?? (Ee?a, 1996), I?aeia?iaei?e eiioa?aioe?? “O?c?ieia?y oa
iaoieia?y ?ioi?oaoo, aaiinoaco oa ia?aeeniiai ieeneaiiy e?i?ae?a”
(Iieoaaa, 1997), tha?eaei?e iaoeiai-i?aeoe/i?e eiioa?aioe??, i?enay/aiee
100??//th c aeiy canioaaiiy 4-? i?nueei? e?ea?i? i. Eoaainueea
(Eoaainuee, 1995), can?aeaiiyo Eoaainueeiai iaeaniiai iaoeiaiai
oiaa?enoaa oa?aiaao?a (1995-97).

No?oeoo?a oa ianya aeena?oaoe??. Aeena?oaoe?y aeeeaaeaia ia 126
noi??ieao iaoeiiieno oa aeeth/a? anooi, iaeyae e?oa?aoo?e, 4 ?icae?e?a
aeanieo aeine?aeaeaiue ? aeniiaee. Nienie aeei?enoaieo aeaea?ae neeaaea?
163 a?o/eciyieo ? 72 ?iicaiieo e?oa?aoo?ieo iineeaiue. Iaoa??aee
aeena?oaoe?? ?ethno?iaaii 19 oaaeeoeyie, 5 ?enoieaie ? 7 ee?i?/ieie
niinoa?aaeaiiyie.

Ioae?eaoe??. ?acoeueoaoe aeena?oaoe?? iioae?eiaai? a 6 iaoeiaeo ?iaioao,
a oiio /ene? 5 noaooyo a oaoiaeo aeaeaiiyo, ? 4 oacao iaoeiaeo
eiioa?aioe?e.

INIIAIEE CI?NO

Iaoa??aee oa iaoiaee aeine?aeaeaiiy

I?ae niinoa?aaeaiiyi ciaoiaeeeinue 208 iaoe??io?a c onoaiiaeaiei
ae?aaiicii OA, ye? aoee ia aeeniaina?iiio iae?eo a Eoaainueeiio
aaiaoieia?/iiio oeaio??, a oiio /ene? 125 (60%) /ieia?e?a ? 83 (40%)
ae?iee. Na?aae ianoaaeaieo ia?aaaaeaee iaoe??ioe iieiaeiai, iaea?eueo
i?aoeacaeaoiiai a?eo – a?ae 21 aei 40 ?ie?a (95 in?a – 76% na?aae
/ieia?e?a ? 68,7% – na?aae ae?iie). A?eueo?noue ianoaaeaieo (174
iniae; 83,7%) aoei ocyoi ia aeeniaina?iee iae?e i?ney ee?i?/ii
iai?oanoiiai caaino?aiiy OA, yea noi?iaiaeaeoaaeinue iayai?noth
neiioii?a iaei? ia/?ieiai? iaaeinoaoiino?, ui iio?aaoaaei e?eoaaiiy a
oiiaao niaoe?ae?ciaaiiai noaoe?iia?o. ?c noiooi?o caoai?thaaiue
aaiaoia?e?a?ii? nenoaie o ianoaaeaieo oai?eo aoee aeyaeai? o?ii?/iee
iaeaeueeoeueiciee oieaoeenoeo (OO) o 74 (35,6%), aeeneeiac?y
aeia/iaea?aeieo oeyo?a ca a?iioii?/iei – o 27 (13,0%) ? a?ia?oii?/iei
oeiii – o 18 (8,7%); ?aaeoeaiee iaie?aaoeo – o 26 (12,6%)

sse i?aaeei, niinoa??aa?i? iaoe??ioe iinooiaee i?ae iaaeyae i?ae /an
caaino?aiiy iaoieia?/iiai i?ioeano a ia/?ioe? aai a oac? iaiiaii?
?ai?n??; aiie aoee ianoaaeai? ia iayai?noue a e?ia? HBsAg oa ?ioeo
ia?ea??a AA A – HBaAg ?aae?i?ioiiei iaoiaeii, aioe-HBn ? aioeHBa –
?ioiioa?iaioiei iaoiaeii (?OA), a oaeiae aioeo?e aei a??ono aaiaoeoo N
(aioe HNV-aioeo?e eean?a Ig I ? Ig G). Aei ?ic?iaee ia aoee aeeth/ai?
iniae, o yeeo aeyaeaii HBsAg, a oaeiae aioeo?ea aei a??on?a aaiaoeo?a A
? N. Oaeei /eiii, iniiaiei ae?aaiicii o niinoa??aa?ieo iaoe??io?a aoa
o?ii?/iee oiene/iee aaiaoeo oa aaiaoeo c iaaoi/iaiith ao?ieia??th
(e?eioiaaiiee) c i?i?iaeueiith oa iii??iith aeoeai?noth i?ioeano.

An? ianoaaeai? oai?? aoee ?aiaeii?ciaaii ?iciiae?eai? ia aea? a?oie.
I?ney anoaiiaeaiiy ee?i?/iiai ae?aaiico, a caeaaeiino? a?ae ae?aaeaiino?
ee?i?ei-eaai?aoi?ieo cnoa?a cae?enithaaeinue e?eoaaiiy a oiiaao
aeiaaiiai noaoe?iia?o, noaoe?iia?o ia aeiio aai
aiaoeaoi?ii-iie?ee?i?/ieo oiiaao. Eiiieaen e?eoaaeueieo caoiae?a
aeeth/aa ?aaeei ? ae??oo (noie ? 5), i?ecia/aiiy niaciie?oee?a
(iaiaaa?ei, ii-oia, ieao?o?e?i) i?e iayaiino? aieueiaiai neiae?iio,
aaiaoii?ioaeoi??a (anaioe?aea, ea?n?e, n?e?ai?), o?oii?aia?ao?a oiui.
I?e iayaiino? caiaeueiiai i?ioeano a aeia/iaea?aeieo oeyoao i?ecia/aany
oo?acie?aeii, aii?oeee?i, aii?ien.

Iaoe??ioe iniiaii? a?oie (102 iniae) aeiaeaoeiai iaea?aeoaaee II ii 0,5
a o?e/? ia aeaiue ? nieai?i ii 2 ie aea?/? ia aeaiue aioo??oiueii’yciai
i?ioyaii i?ioyaii 10 ae?a. ?aooa 106 niinoa??aa?ieo iaoe??io?a aoee
aeeth/ai? aei a?oie ni?anoaaeaiiy.

Oai?ei iaio a?oi cae?enithaaany eiiieaen ee?i?ei?ino?oiaioaeueiiai ?
a?io?i?/iiai ianoaaeaiiy aeey aoi/iaiiy ae?aaeaiino? ? oa?aeoa?a
o?aaeaiiy ia/?iee, aeia/iaea?aeieo oeyo?a, i?aeoeoieiai? caeice. Aeey
oa?aeoa?enoeee i?aai?a /a?aaii? ii?iaeieie aoee canoiniaai? OAAeN ?
OCAe. Ianya iaia’yceiaiai a?io?i?/iiai ianoaaeaiiy aeeth/aa aecia/aiiy
a?e??oa?io ? eiai o?aeoe?e (a?eueii? oa ca’ycaii?), aeoeaiino?
ai?iio?ainoa?ac   AeAO ? AnAO, aene?aoi?ieo oa?iaio?a (eoaeii? oinoaoace
– EO ? aaiaaeooai?eo?ainiaioeaeace – AAOI), iieaciee?a inaaeeiaeo
?aaeoe?e – noeaiiai? ? o?iieiai?, ??aiy oieanoa?eio,
aaoa-e?iii?ioa?ae?a, caaaeueiiai a?eea ? a?eeiaeo o?aeoe?e, oeoe?a
e?ia?, i?io?iia?iiaiai ?iaeaeno oi?o?eiaaieie iaoiaeaie. Ii?yae c oeei
aeey oa?aeoa?enoeee ae?aaeaiino? NI? aecia/aee ??aaiue “na?aaei?o
iieaeoe” (NI) a ne?iaaooe? e?ia? niaeo?ioioiiao?e/iei iaoiaeii
(A.A. I?eieae/?e ? ni?aaao., 1991). Aea/aee noai aia?aaoe/iiai
iaoaaie?cio oeyoii aecia/aiiy ??aiy aaeai?eiaeo ioeeaioeae?a – AOO,
AAeO, AIO iaoiaeii oiieioa?iai? o?iiaoia?ao?? ia ieanoeiao “Silufol”.
I?e oeiueio ae?aoiaoaaee AC ee?oei ye ni?aa?aeiioaiiy AOO/(AAeO+AIO).
Aeine?aeaeoaaee oaeiae noia?io aeoeai?noue ne?iaaoi/iie
eaeoaoaeaa?ae?iaaiace (EAeA) – eeth/iaiai oa?iaioo ae?eie?ca ? eiai
?cioa?iaioiee niaeo? oeyoii aeaeo?ioi?aco a iie?aae?eeai?aeiiio aae? ia
aia?ao? IAO-3. ?ioaineai?noue i?ioean?a IIE ioe?ithaaee ca ??aiai
e?ioeaaiai i?iaeoeoo ia?ieneaeaoe?? – iaeiiiaiai aeeaeueaeaa?aeo (IAeA)
? i?ii?aeieo i?iaeoeo?a – ae??iiaeo eii’thaao?a (AeE)
niaeo?ioioiiao?e/ii (A.A. Aaa?eeia ? I.?. I?oei?oaeia, 1983). Aeey
noaeaeaiiy i?i noai nenoaie aioeieneaeaioiiai caoenoo (AIC) aea/aee
aeoeai?noue oa?iaio?a – eaoaeace (EO) ? noia?ieneaeaeeniooace (NIAe)
niaeo?ioioiiao?e/iei iaoiaeii. ?ic?aoiaoaaany ?iaeaen O, yeee a?aeaeaa?
eiiiainaoi?ii-i?enoinoaaeuei? iiaeeeaino? AIC ia i?aeaeuaiiy IIE, ca
oi?ioeith O=(EO*NIAe)/IAeA (N.*aaa?e ? ni?aaao., 1991).

I?e aecia/aii? e?euee?nieo iieaciee?a ee?oeiiiai ?ioi?oaoo – O- ?
Ae?ioioeeo?a, O-oaeia??a/?iaeoeoi??a, O-noi?ani??a/e?ea??a
canoiniaoaaany oeeoioiene/iee oano ?c canoinoaaiiyi iiiieeiiaeueieo
aioeo?e eean?a CD-3, CD-22, CD-4, CD-8 o??ie Ortho Dyagnostic Systems
Inc. (NOA). Aeine?aeaeaiiy ai?noo Oe?E o ne?iaaooe? e?ia?
cae?enithaaeinue oeyoii aeeoa?aioe?eiaaii? i?aoeei?oaoe?? a ?ic/eiao
iie?aoeeaiae?eieth c iieaeoey?iith ianith 6000 aeaeueoii iiaeeo?eiaaiei
caniaii (A.I. O?ieia ? ni?aaao., 1986). I?ae?aoiaoaaee noia?iee ai?no a
ne?iaaooe? e?ia? na?aaeiuei oa ae??aiiiieaeoey?ieo ?ioiieo eiiieaen?a ye
iaea?eueo iaoiaaiieo. Aeey ioe?iee oaaioeeoa?ii? aeoeaiino? iiiioeeo?a
(OAI) canoiniaoaaany /aoa/eiaee can?a (A.I. O?ieia ? ni?aaao., 1989).
sse oano-ia’?eo oaaioeeoico aeei?enoiaoaaee aeeao aeiaiao eoeueoo?o
Staph. aureus, ooai 505.

A yeino? ii?ie a?io?i?/ieo ? ?ioiieia?/ieo iieaciee?a aeei?enoai? aeai?
i?aeeaoaae?aeueii? ?ioiieia?/ii? eaai?aoi??? EAeIO. Aeeniaina?iee
iaaeyae ianoaaeaieo iaoe??io?a i?iaiaeeany i?ioyaii 2-3-o ?ie?a 3-4 ?ace
ia ??e, i?e iaiao?aeiino? – /ano?oa. I?e oeueiio a?aoiaoaaee /anoioo
caaino?aiue iaoieia?/iiai i?ioeano a i?aaiao aaiaoia?e?a?ii? nenoaie,
aeeiai?eo a?io?i?/ieo oa ?ioiieia?/ieo iieaciee?a, o?eaae?noue ? iiaiiio
aeinyaiooi? ?ai?n??. Iaoaiaoe/ia ia?iaea io?eiaieo aeaieo
cae?enithaaeanue ia IAII Pentium Celeron 300A c aeei?enoaiiyi
noaiaea?oiiai iaeaoo i?eeeaaeieo i?ia?ai, ?ic?aoiaaieo ia ia?iaeo
ee?i?/ii?, a?io?i?/ii? oa ?ioiieia?/ii? ?ioi?iaoe??.

Aieea cai?iiiiiaaiiai e?eoaaiiy ia ee?i?/i? iieacieee

Ee?i?/ia ea?oeia caaino?aiiy OA o ianoaaeaieo oai?eo oa?aeoa?ecoaaeanue
neaae?noth, iacaeoaeaiiyi, cieaeaiiyi i?aoeacaeaoiino?, oyaee?noth a
i?aaiio i?ae?aaa?’?, a 42,5% aeiaaee?a – aieueiaei neiae?iiii (i?e
iayaiino? o?aaeaiue aeia/iaea?aeieo oeyo?a). I?e iaeueiaoi?iiio
ianoaaeaii? ca?eueoaiiy ?ici???a ia/?iee anoaiiaeaii o an?o
niinoa?aaeaiieo. I?e iaeueiaoe?? ia/?iee /ooeea?noue e?ath ia/?iee
aeyaeaia o 63,5% ianoaaeaieo. Iiceoeaiee neiioii Ea?a a?aei?/aany o 36%
iaoe??io?a. Neiioii I?oia?a aeyaeyany a 5,7% niinoa?aaeaiue.
Noa?eoa?e/i?noue neea? ? oe??e a?aei?/aia a 53,8% aeiaaee?a, iayai?noue
aeiaoyieoe? – o 46,2%. O an?o oai?eo aeyaeyeenue “ia/?ieia?” iciaee,
oae? ye iaeueia?ia a?eoaia, oaeaaia?iaeoac?? oa ?io. Ee?i?/ii
iai?oanoi? iciaee oieanoaco (?ioaineaiee naa?a?ae oe??e oa ?io.) aoee
a?aei?/ai? a 25% aeiaaee?a.

I?aeaeuaiiy ??aiy a?e??oa?io a iaaeao 22-30 ieiieue/e a?aei?/aii o 47,1%
oai?eo, 31-60 ieiieue/e – o 35,6% oa 61-95 ieiieue/e – o ?aooe 17,3%.
I?ae /an caaino?aiiy i?aeaeuaiiy aeoeaiino? AeAO a iaaeao 1,8-2,0
iiieue/aiae*e iaea i?noea a 40,9% aeiaaee?a, 2,1- 3,0 iiieue/aiae*e – a
33,6%, 3,1-3,6 iiieue/aiae*e – a 25,5%. Iieaciee o?iieiai? i?iae
neeaaeaa 6-8 iae. – o 38,9% in?a, 9-11 iae. – 36,0%, 12-14 iae. –
25,1%. I?aeaeuaiiy ??aiy AAOI a iaaeao a?ae 2200 aei 3000 iiieue/aiae*e
a?aei?/aii a 26,4% , 3000-3800 iiieue/aiae*e – a 12,0% aeiaaee?a.

I?iaaaeaiiy OCAe i?aai?a /a?aaii? ii?iaeieie aeicaieyei a?aecia/eoe
iayai?noue aaiaoiiaaae?? o an?o ianoaaeaieo, iii??ii? nieaiiiaaae?? o
25 oai?eo (12,0%); i?aeaeuaia eoiiaai?noue ia/?iee aeyaeaia o 148
(71,1%), ia??aiii??i?noue eoiiaaiino? – a 19,9%; ca?eueoaiiy ae?aiao?o
v. ?ortae – a 10,1% aeiaaee?a. A 36,6% aeiaaee?a anoaiiaeai? ci?ie c
aieo iicaia/?ieiaeo aeia/iaea?aeieo oeyo?a, ye? iieyaaee o noiauaii?
no?iee aeia/iiai i?oo?a, iayaiino? a eiai i?ina?o? aeao?eoo – “caiacee”,
ia?aoeiee aeia/iiai i?oo?a niaeeaie, ui a ee?i?/iiio ieai? ni?aniaaeaei
?c iayai?noth ? a iece? aeiaaee?a caaino?aiiyi iaeaeueeoeueiciiai OO.

A aeeiai?oe? e?eoaaiiy ?c canoinoaaiiyi II ? nieai?io a iniiai?e a?oi?
a?aei?/aii ae?aaeaiee iiceoeaiee aieea ia ee?i?/i? iieacieee. I?ney
caaa?oaiiy eo?no e?eoaaiiy a 87,3% aeiaaee?a oaeoe/ii ia i?aae’yaeyee
nea?a; a 83,3% aeiaaee?a cieeea aie?ni?noue a ai?aano??? ? i?aaiio
i?ae?aaa?’?. Nea?ae ia ii/oooy oyaeeino? a i?aaiio i?ae?aaa?’? iiaeaaaee
eeoa 11,8% iaoe??io?a iniiaii? a?oie. A?aei?/aeinue nei?i/aiiy
o?eaaeino? neiae?iio aeiaoyieoe? ia 5,4±0,2 aei? o ii??aiyii? c a?oiith
ni?anoaaeaiiy, a?eueo oaeaeea e?ea?aeaoe?y neiae?iio oeeoie?co (ia
4,8±0,4 aei? ?ai?oa), cieeiaiiy anoai?/ii? neiioiiaoeee (ia 5,8±0,3
aeiae ?ai?oa).

Aeeniaina?iee iaaeyae i?ioyaii 6-12 i?n aeicaieea a?aei?oeoe, ui o
oai?eo iniiaii? a?oie iaei i?noea a?eueo oaeaeea ciaioaiiy ?ici???a
ia/?iee ? naeac?iee ? aeinyaiaiiy iiaiioe?iii? ee?i?/ii? ?ai?n??,
iieacieeaie /iai c’yaeeenue ii?iae?caoe?y ooieoe?iiaeueieo i?ia ia/?iee.

Noia?ii aa?i? ?acoeueoaoe e?eoaaiiy c aeinyaiaiiyi no?eei? ?ai?n?? a
a?oi? oai?eo, ye? io?eiaee II ? nieai?i, aoee a 2,5 ?ace /ano?oa, i?ae
i?e e?eoaaii? caaaeueiii?eeiyoeie caniaaie (87,2% ? 34,8%
a?aeiia?aeii). Iieaciai, ui aeinyaiaiiy no?eei? ee?i?ei-a?io?i?/ii?
?ai?n?? OA a iniiai?e a?oi? i?ioyaii iaeiiai ?ieo ? a?eueoa aaea i?ney
iaeiie?aoiiai eo?no oa?ai?? a?aei?/aeinue a 80,1%. Iiaoi?iiai
i?iaaaeaiiy eo?no e?eoaaiiy c aeeth/aiiyi II ? nieai?iii i?ae /an
aeeniaina?iiai niinoa?aaeaiiy iio?aaoaaee 19,9% oai?eo iniiaii? a?oie.
Iayai?noue ae?aaeaieo caaino?aiue caoai?thaaiiy c ?icaeoeii aeiaoyieoe?,
ui iio?aaoaaei aini?oae?caoe?? oai?eo, a iniiai?e a?oi? a?aei?/aii a
4,9% aeiaaee?a. A a?oi? ni?anoaaeaiiy no?eea ee?i?ei-a?io?i?/ia ?ai?n?y
aeinyaiooa o 39,6% oai?eo, a /anoioa aini?oae?caoe?? oai?eo ?c
ae?aaeaiei caaino?aiiyi OA iaea i?noea a 15,1% aeiaaee?a.

Ioaea, aeei?enoaiiy cai?iiiiiaaii? eiia?iaoe?? oa?iaeii?aia?ao?a
(ioeea?iaoo iao??y ? nieai?io) o oai?eo ia OA ni?ey? cieaeaiith
ae?aaeaiino? oieneeico, oaiaeaioe?? aei ii?iae?caoe?? a?io?i?/ieo
iieaciee?a.

Aeeiai?ea iaoaaie?/ieo iieaciee?a o ianoaaeaieo oai?eo ia OA

O ianoaaeaieo oai?eo ia OA a iaio a?oiao i?ae /an caaino?aiiy
iaoieia?/iiai i?ioeano a ia/?ioe? niinoa??aaeinue ?noioia c?inoaiiy
??aiy NI a e?ia? a na?aaeiueiio aei 2,38±0,21 a/e (i?e ii?i? 0,52±0,04
a/e, P0,05), e?ea?aeaoe?y aeenaaeaino
?aaoeyoi?ieo noaiiioeyoe?e O-ee?oei c oaiaeaioe??th aei ii?iae?caoe??
?ioii?aaoeyoi?iiai ?iaeaeno CD4/CD8, oiaoi c?inoaiiy a na?aaeiueiio aei
1,8±0,02 i?e eiai aeo?aeii cieaeaiiio cia/aii?. Ii?yae c oeei
i?aeaeuoaaeenue iieacieee OAI, iniaeeai ?iaeaen ia?ao?aaeaiiy (a 1,7
?ac?a ii a?aeiioaiith aei aeo?aeiiai cia/aiiy, ui aei??aithaaei
18,3±1,2) ? oaaioeeoa?iee ?iaeaen (a 1,8 ?ac?a, oiaoi aei 3,7±0,3).
??aaiue Oe?E ?noioii cieaeoaaany (aei 2,3±0,3 a/e i?e cia/aii? aei
ii/aoeo e?eoaaiiy 4,6±0,6 a/e, P>0,05). Oea noi?iaiaeaeoaaeinue /?oei
ae?aaeaiith oaiaeaioe??th aei ii?iae?caoe?? ?o iieaeoey?iiai neeaaeo,
ia?aaaaeii ca ?aooiie cieaeaiiy eiioeaio?aoe?? iaea?eueo iaoiaaieo
na?aaeiuei- ? ae??aiiiieaeoey?ieo ?ioiieo eiiieaen?a a na?aaeiueiio a
1,3 ?ace (aei 62,1±1,6% i?e ii?i? 56,6±2,2%; P>0,05). Ii?iae?caoe?y
?ioiieia?/ieo iieaciee?a i?ney caaa?oaiiy cai?iiiiiaaiiai e?eoaaiiy a
iniiai?e a?oi? a?aei?/aia o 61,8% oai?eo oa cia/ia ?o iie?auaiiy – ua o
31,4%. I?e aeeniaina?iiio niinoa?aaeaii? i?ioyaii 2-3-o ?ie?a aeyaeaii
iiaeaeueoa ?o iie?auaiiy, i?e oeueiio /a?ac 6 i?n i?ney caaa?oaiiy
e?eoaaiiy ii?iae?caoe?y ?ioiieia?/ieo iieaciee?a a?aei?/aia o 82,4%
iaoe??io?a iniiaii? a?oie.

A a?oi? ni?anoaaeaiiy ia a?aecia/aii no?eue ae?aaeaii? iiceoeaii?
aeeiai?ee aea/aieo ?ioiieia?/ieo iieaciee?a, ui i?iyaeeinue caa?aaeaiiyi
ia iaoieia?/iiio ??ai? eiioeaio?aoe?? O-e?ioioeeo?a, aeecaaeaino
oaeia?iinoi?ani?ieo noaiiioeyoe?e O-ee?oei, aenieei ??aiai Oe?E,
iniaeeai o?aeoe?e na?aaeiuei ? ae??aiiiieaeoey?ieo ?ioiieo eiiieaen?a.
I?e oeueiio ii?iae?caoe?y ae/aieo ?ioiieo iieaciee?a iae?iaoeue
e?eoaaiiy a?aei?/aia eeoa a 37,7% aeiaaee?a; a oie aea /an o 13,2%
iaoe??io?a iaea i?noea a?aenooi?noue aoaeue-yei? aeeiai?ee ?ioiieo
iieaciee?a ? naia o ieo aeyaeany oneeaaeiaiee ia?aa?a OA (caoyaeiee
ia?aa?a, /ano? ?aoeeaeeae caoai?thaaiiy).

Oaeei /eiii, aeeth/aiiy II ? nieai?io aei eo?no e?eoaaiiy OA ni?ey?
aeinyaiaiith no?eei? ? a?eueo o?eaaei? ee?i?/ii? ?ai?n??, iie?ioaiith
a?eueoino? ?ioiieia?/ieo iieaciee?a, a oaeiae a?aeiiaeaiith
iaoaaie?/iiai aiiainoaco. Aeeniaina?iee iaaeyae i?ioyaii iaeiiai ?ieo
iieacaa, ui a iniiai?e a?oi? noieea ee?i?ei-a?io?i?/ia ?ai?n?y
aeinyaiooa o 82 oai?eo, ui neeaei 80,1%; a a?oi? ni?anoaaeaiiy – o 42
(39,6%), oiaoi a 2 ?ace ??aeoa. Iayai?noue ae?aaeaieo caaino?aiue
caoai?thaaiiy c ?icaeoeii aeiaoyieoe?, ui iio?aaoaaei aini?oae?caoe??
oai?eo, a iniiai?e a?oi? a?aei?/aii o 5 (4,9%), a a?oi? ni?anoaaeaiiy
– o 16 (15,1%), oiaoi a 3,1 ?ac?a /ano?oa.

Io?eiai? aeai? aeicaieythoue aaaaeaoe aeioe?eueiei aeeth/aiiy ioeea?iaoo
iao??y ? nieai?io aei eiiieaenii? oa?ai?? oai?eo ia OA.

AENIIAEE

1. Aeeth/aiiy eiia?iaoe?? II ? nieai?io aei eiiieaenii? oa?ai?? oai?eo
ia OA ni?ey? a?eueo oaeaee?e e?ea?aeaoe?? neiioii?a ?ioieneeaoe?? ?
iaoieia?/ieo ci?i c aieo aaiaoia?e?a?ii? nenoaie, aeinyaiaiith
iiaiioe?iii? ee?i?eia?io?i?/ii? ?ai?n?? o?eaae?noth ia iaioa iaeiiai
?ieo o 80,1% oai?eo.

2. Aeei?enoaiiy eiia?iaoe?? II ? nieai?io a e?eoaaii? oai?eo ia OA
iaoiiaeth? ii?iae?caoe?th ?ioiieo iieaciee?a a 61,8% ? ?o nooo?aa
iie?auaiiy – a 31,4%, a oie /an ye a a?oi? ni?anoaaeaiiy eeoa a 37,7% ?
16,0% aeiaaee?a a?aeiia?aeii.

3. Anoaiiaeaii iiceoeaiee aieea II ? nieai?io ia iieacieee
aia?aaoe/iiai iaoaaie?cio ? nenoaie aioeieneaeaioiiai caoenoo o oai?eo
ia OA, cieaeaiiy i?ae aieeaii i?iaaaeaiiai e?eoaaiiy ae?aaeaiino?
ia?ieneaeaoe?? e?i?ae?a ? c?inoaiiy aeoeaiino? oa?iaio?a nenoaie AIC.

4. A a?oi? oai?eo, ye? io?eiaee II ? nieai?i, aaea?/? /ano?oa, i?ae
i?e e?eoaaii? caaaeueiii?eeiyoeie caniaaie, a?aei?/aii aeinyaiaiiy
no?eei? ee?i?ei-a?io?i?/ii? ?ai?n?? OA o?eaae?noth iaeei ??e ? a?eueoa
aaea i?ney iaeiie?aoiiai eo?no oa?ai??; 19,9% oai?eo iio?aaoaaee
iiaoi?iiai i?iaaaeaiiy 1-2 eo?n?a e?eoaaiiy c aeeth/aiiyi II ? nieai?io.

5. Iieacaiiyie aeey i?ecia/aiiy II ? nieai?ia oai?ei ia OA ne?ae
aaaaeaoe /ano? caaino?aiiy iaoieia?/iiai i?ioeano, iayai?noue aoi?eiieo
?ioiiaeao?oeeoieo noai?a ? neiae?iio aiaeiaaiii? “iaoaaie?/ii?”
?ioieneeaoe??, noeeuei?noue aei aea?a?/ieo ?aaeoe?e, iaaeinoaoith
aoaeoeai?noue caaaeueiii?eeiyoeo aaiaoii?ioaeoi??a.

NIENIE I?AOeUe, IAAe?OEIAAIEO CA OAIITH AeENA?OAOe??

1. Iaea?aiei A.A. Eeeieei-aeioeie/aneea iniaaiiinoe e ea/aiea
o?iie/aneeo aaiaoeoia iaae?oniie yoeieiaee a oneiaeyo e?oiiiai
i?iiuoeaiiiai ?aaeiia Aeiiaanna // Cae?aaiio?aiaiea Aeiiaanna. – 1997.
– Aei. 2. – N. 56-59.

2. Iaea?aiei A.A. ?ioiieia?/i? ii?ooaiiy o oai?eo ia o?ii?/iee aaiaoeo
?c noiooiueith iaoieia??th aeia/iaea?aeieo oeyo?a // I?iaeaie
aeieia?/ii? oa iaaee/ii? aaiaoeee ? ee?i?/ii? ?ioiieia??: Ca.
iaoeiaeo i?aoeue. – Ee?a; Eoaainuee, 1997. – Aei. 1. – N. 100-104.

3. Iaea?aiei A.A. Aeei?ecoaiiy ioeea?iaoo iao??y ? nieai?io a e?eoaaii?
oai?eo ia o?ii?/i? o?aaeaiiy ia/?iee // I?iaeaie aeieia?/ii? oa
iaaee/ii? aaiaoeee ? ee?i?/ii? ?ioiieia??: Ca. iaoeiaeo i?aoeue. –
Ee?a; Eoaainuee, 1998. – Aei. 2. – N. 92-99.

4. Iaea?aiei A.A. Neiae?ii “iaoaaie?/ii? ?ioieneeaoe??” oa noai
aia?aaoe/iiai iaoaaie?cio a iaoiaaiac? o?ii?/iiai o?aaeaiiy
aaiaoia?e?a?ii? nenoaie // I?iaeaie aeieia?/ii? oa iaaee/ii? aaiaoeee
? ee?i?/ii? ?ioiieia??: Ca. iaoeiaeo i?aoeue. – Ee?a; Eoaainuee, 1998.
– Aei. 3. – N. 242-249.

5. Iaea?aiei A.A. Iaoiaaiaoe/aneia iainiiaaiea i?eiaiaiey ioeeaeiaoa
iao?ey a eiiaeiaoeee ni nieaieiii i?e o?iie/aneie iaoieiaee
aaiaoiaeeea?iie nenoaiu // I?iaeaie aeieia?/ii? oa iaaee/ii? aaiaoeee
? ee?i?/ii? ?ioiieia??: Ca. iaoeiaeo i?aoeue. – Ee?a; Eoaainuee, 1999.
– Aei. 1. – N. 130-137.

6. Iaea?aiei A.A., Oa?aoei A.A., Aeaeaethe E.A. Eiioiieiae/aneea,
oeeoiaaiaoe/aneea ia?ooaiey e ninoiyiea iee?iaaiiaeeiaieee o aieueiuo n
o?iie/aneie iaoieiaeae ia/aie // I?iaeaie aeieia?/ii? oa iaaee/ii?
aaiaoeee ? ee?i?/ii? ?ioiieia??: Ca. iaoeiaeo i?aoeue. – Ee?a;
Eoaainuee, 1999. – Aei. 2. – N. 155-162.

AIIOAOe?ss

Iaea?aiei A.A. Aoaeoeai?noue ioeea?iaoo iao??y ? nieai?io a
eiiieaeni?e oa?ai?? oa ?aaa?e?oaoe?? o?ii?/ieo caoai?thaaiue
aaiaoia?e?a?ii? nenoaie. – ?oeiien.

Aeena?oaoe?y ia caeiaoooy a/aiiai nooiaiy eaiaeeaeaoa iaaee/ieo iaoe ca
oaoii 14.01.02 – aioo??oi? oai?iae. – Eoaainueeee aea?aeaaiee iaaee/iee
oi?aa?neoao. – Eoaainuee, 1998.

Aeena?oaoe?y aeeth/a? ?acoeueoaoe eiiieaeniiai ee?i?ei?ioiieia?/iiai,
a?io?i?/iiai oa ?ino?oiaioaeueiiai ianoaaeaiiy 208 oai?eo ia o?ii?/i?
aaiaoeoe (OA). Anoaiiaeaii, ui aeeth/aiiy eiiieaeno ioeea?iaoo iao??y ?
nieai?io ca cai?iiiiiaaiith noaiith aeiaeaoeiai aei caaaeueiii?eeiyoeo
iaoiae?a oa?ai?? OA i?aeaeuo? aoaeoeai?noue e?eoaaiiy, ni?ey? a?eueo
oaeaeeiio ianoaiith ?aa?an?? caaaeueii?ioaeoe?eieo ? i?noeaaeo i?iya?a
caoai?thaaiiy, aeinyaiaiith iiaiioe?iii? ee?i?/ii? ?ai?n??, a oaeiae
e?ea?aeaoe?? aeo?aeii aeyaeaieo a?io?i?/ieo ? ?ioiieia?/ieo cnoa?a. Iaio
ae?aaeaia aeeiai?ea aea/aieo iieaciee?a a?aei?/aia i?e oyaeeiio ia?aa?ao
OA oa niieo/aii? ?o ?c o?ii?/iith iaoieia??th aaiaoia?e?a?ii? nenoaie.
Aeei?enoaiiy eiia?iaoe?? ioeea?iaoo iao??y ? nieai?io iaoiiaeth?
ii?iae?caoe?th ?ioiieo iieaciee?a o 61,8% ianoaaeaieo oai?eo ? nooo?aa
?o iie?auaiiy – o 31,4%. A a?oi? oai?eo, ye? io?eiaee ioeea?iao iao??y
? nieai?i, a 2,0 ?ace /ano?oa, i?ae i?e e?eoaaii? caaaeueiii?eeiyoeie
caniaaie, a?aei?/aii aeinyaiaiiy no?eei? ee?i?ei-a?io?i?/ii? ?ai?n?? OA
o?eaae?noth ia iaioa iaeiiai ?ieo aaea i?ney iaeiie?aoiiai eo?no
oa?ai??; 19,9% oai?eo iio?aaoaaee iiaoi?iiai i?iaaaeaiiy 1-2 eo?n?a
e?eoaaiiy c aeeth/aiiyi II ? nieai?io.

Eeth/ia? neiaa: o?ii?/iee aaiaoeo, neiae?ii “iaoaaie?/ii?”
?ioieneeaoe??, ia?aeenia ieeneaiiy e?i?ae?a, aia?aaoe/iee iaoaaie?ci,
?ioi?oao, ioeea?iao iao??y, nieai?i

AIIIOAOeEss

Iaea?aiei A.A. Yooaeoeaiinoue ioeeaeiaoa iao?ey e nieaieia a
eiiieaeniie oa?aiee e ?aaaeeeoaoeee o?iie/aneeo caaieaaaiee
aaiaoiaeeea?iie nenoaiu. – ?oeiienue.

Aeenna?oaoeey ia nieneaiea o/aiiai noaiaie eaiaeeaeaoa iaaeeoeeineeo
iaoe ii niaoeeaeueiinoe 14.01.02 – aioo?aiiea aieacie. – Eoaaineee
ainoaea?noaaiiue iaaeeoeeineee oieaa?neoao. – Eoaaine, 1998.

Aeenna?oaoeey iinayuaia o?iie/aneie iaoieiaee ia/aie, eioi?ay
oa?aeoa?ia aeey eiaeono?eaeueiiai ?aaeiia Aeiiaanna, /oi aeaeaao ?aaioo
aeooaeueiie. O?aaeeoeeiiiay oa?aiey, eniieuecoaiay i?e ea/aiee
o?iie/aneeo aaiaoeoia, ia anaaaea aeinoeaaao aeaeaaiiai ?acoeueoaoa.
Iiyoiio, oeaeueth aeaiiie ?aaiou yaeeanue ?ac?aaioea yooaeoeaiiai
niiniaa ea/aiey e ?aaaeeeoaoeee aieueiuo o?iie/aneei ii?aaeaieai
aaiaoiaeeea?iie nenoaiu ?acee/iie yoeieiaee n eniieueciaaieai ioeeaeiaoa
iao?ey e nieaieia. Auei ianeaaeiaaii 208 aieueiuo n aunoaaeaiiui
aeeaaiicii o?iie/aneee aaiaoeo (OA), eioi?ua iaoiaeeeenue iiae
aeeniaina?iui iaaethaeaieai a Eoaaineii aaiaoieiae/aneii oeaio?a.
Aic?ano iaoeeaioia ninoaaeye io 21 aei 40 eao. Anai aieueiui i?iaiaeeee
eiiieaeniia eeeieei- eino?oiaioaeueiia enneaaeiaaiea ia/aie,
aeioeie/aneia e eiioiieiae/aneia ianeaaeiaaiea. Onoaiiaeaii, /oi
aeeth/aiea eiiieaena ioeeaeiaoa iao?ey e nieaieia ii i?aaeeiaeaiiie
noaia aeiiieieoaeueii e iauai?eiyoui iaoiaeai oa?aiee OA iiauoaao
yooaeoeaiinoue ea/aiey, niaeaenoaoao aieaa auno?iio ianooieaieth
?aa?annee iauaeioieneeaoeeiiiuo e ianoiuo i?iyaeaiee caaieaaaiey,
aeinoeaeaieth iieiioeaiiie eeeie/aneie ?aiennee, a oaeaea eeeaeaeaoeee
enoiaeii auyaeaiiuo aeioeie/aneeo e eiioiieiae/aneeo naeaeaia. Iinea
caaa?oaiey eo?na ea/aiey a 87,3% neo/aaa, aieueiua oaeoe/anee ia
i?aaeuyaeyee aeaeia; a 83,3% – en/acea aieaciaiiinoue a yieaano?ee e
i?aaii iiae?aaa?uee. Ioia/aeinue /aoei au?aaeaiiia iieiaeeoaeueiia
aeeyiea eiiaeiaoeee ioeeaeiaoa iao?ey e nieaieia ia aeioeie/aneea
iieacaoaee: nieaeaiea o?iaiy n?aaeieo iieaeoe a n?aaeiai a 2,4 ?aca;
oaiaoaiea i?ioeannia ia?aeeniiai ieeneaiey eeieaeia (aeinoiaa?iia
nieaeaiea niaea?aeaiey aeeaiiauo eiiuthaaoia, iaeiiiaiai
aeeaeueaeaaeaea); iiauoaiea enoiaeii nieaeaiiie aeoeaiinoe eaoaeacu e
noia?ieneaeaeeniooacu. Eniieueciaaiea eiiaeiaoeee ioeeaeiaoa iao?ey e
nieaieia iaoneiaeeaaao ii?iaeecaoeeth eiioiiuo iieacaoaeae a 61,8%
ianeaaeiaaiiuo aieueiuo e nouanoaaiiia oeo/oaiea – a 31,4%. A a?oiia
aieueiuo, eioi?ua iieo/eee ioeeaeiao iao?ey e nieaiei, a 2,0 ?aca /aua,
/ai i?e ea/aiee iauai?eiyouie niiniaaie, ioia/aii aeinoeaeaiea noieeie
eeeieei-aeioeie/aneie ?aienee OA i?iaeieaeeoaeueiinoueth aieaa iaeiiai
aiaea oaea iinea iaeiie?aoiiai eo?na oa?aiee; 19,9% aieueiie o?aaiaaee
iiaoi?iiai i?iaaaeaiey 1-2 eo?nia ea/aiey n aeeth/aieai ioeeaeiaoa
iao?ey e nieaieia.

Eeth/aaua neiaa: o?iie/aneee aaiaoeo, neiae?ii “iaoaaiee/aneie”
eioieneeaoeee, ia?aeeniiai ieeneaiey eeieaeia, yia?aaoe/aneee
iaoaaieeci, eiioieoao, ioeeaeiao iao?ey, nieaiei.

SUMMARY

Makarenko V.G. Efficiency of natrii nucleinas and splenini in complex
therapy and rehabilitation of chronic diseases of hepatobiliar system. –
Manuscript.

The dissertation for a scientific degree of the candidate of medical
sciences on a speciality 14.01.02 – internal diseases. – Lugansk state
medical university, Lugansk, 1999.

The dissertation includes results of complex clinico-immune, biochemical
and tool inspection of 208 patients with chronic hepatitis. It was
established, that the inclusion of a complex of natrii nucleinas and
splenini under the offered circuit in addition to the standard methods
of therapy CG raises efficiency of treatment, promotes to faster
approach of regression of generalinfectioas and local displays of
disease, achievement high-grade clinical remission, and also liquidation
of initially revealed biochemical and immune shifts. Less expressed
dynamics of the investigated parameters marked at heavy current CG and
combination them from a chronic pathology of hepatobiliar system. Use of
a combination of natrii nucleinas and splenini causes normalization of
immune parameters at 61,8 % of the surveyed patients and their essential
improvement – at 31,4%. In group of the patients, which have received
natrii nucleinas and splenini in 2,0 times is more often, than at
treatment by the standard ways, is marked achievement proof
clinico-biochemical remission of CG by duration not less than one year
already after a unitary rate of therapy; 19,9 % of the patients required
repeated realization 1-2 rates of treatment with inclusion natrii
nucleinas and splenini.

Keywords: chronic hepatitis, “metabolic” intoxication cyndrom, lipid
peroxidation, power metabolism, immunity, natrii nucleinas, splenin.

I?aeienaii aei ae?oeo 12.04.1999 ?. Oi?iao 60o90/16. Iai??
ae?oea?nueeee. Ae?oe ionaoiee. Oiia. ae?oe. a?e. 1,0. Oe?aae 100 i?ei.
Caiiaeaiiy 323. OIA “AEOII”, 348000, Eoaainuee, aoe. Eioethaeinueeiai, 2

Нашли опечатку? Выделите и нажмите CTRL+Enter

Похожие документы
Обсуждение

Ответить

Курсовые, Дипломы, Рефераты на заказ в кратчайшие сроки
Заказать реферат!
UkrReferat.com. Всі права захищені. 2000-2020